• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低慢性肾脏病儿童心血管疾病负担:预防与损伤控制。

Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.

机构信息

UCL Great Ormond Street Hospital for Children and Institute of Child Health, London, WC1N 3JH, UK.

出版信息

Pediatr Nephrol. 2021 Aug;36(8):2537-2544. doi: 10.1007/s00467-021-05102-y. Epub 2021 Jun 18.

DOI:10.1007/s00467-021-05102-y
PMID:34143301
Abstract

Cardiovascular disease (CVD) is a life-limiting condition in patients with chronic kidney disease (CKD) and is rapidly progressive, especially in those with stage 5 CKD and on dialysis. Cardiovascular mortality, although reducing, remains at least 30 times higher than in the general pediatric population. The American Heart Association guidelines for cardiovascular risk reduction in high-risk pediatric patients has stratified pediatric CKD patients in the "high risk" category for the development of CVD, with associated pathological and/or clinical evidence for manifest coronary disease before 30 years of age. While improving patient survival is a key priority, other patient-related outcomes, such as psychosocial development, quality of life and growth are of major importance to children and their caregivers. Once vascular damage or calcification has developed, there are no data to suggest that they can be reversed. Treatments such as intensified dialysis and transplantation may attenuate the progression of subclinical cardiovascular disease, but no treatment to date has shown that the inexorable progression of CVD in CKD can be reversed. Thus, our management must focus on early diagnosis and robust preventative strategies to give our patients the best chance of optimal cardiovascular health and survival. In this review, the pathophysiology and importance of preventing the development of CVD in CKD is discussed.

摘要

心血管疾病(CVD)是慢性肾脏病(CKD)患者的一种危及生命的疾病,且其进展迅速,尤其是在 5 期 CKD 患者和透析患者中。尽管心血管死亡率有所下降,但仍至少比普通儿科人群高 30 倍。美国心脏协会(AHA)为高风险儿科患者制定的心血管风险降低指南将儿科 CKD 患者分层为 CVD 发病的“高危”类别,其具有明显冠状动脉疾病的病理和/或临床证据,发病年龄在 30 岁之前。虽然提高患者生存率是一个关键的优先事项,但其他与患者相关的结局,如心理社会发展、生活质量和生长,对儿童及其照顾者来说非常重要。一旦发生血管损伤或钙化,就没有数据表明它们可以逆转。强化透析和移植等治疗方法可能会减缓亚临床心血管疾病的进展,但迄今为止,没有任何治疗方法表明 CKD 中 CVD 的不可避免进展可以逆转。因此,我们的治疗必须侧重于早期诊断和强有力的预防策略,以使我们的患者有最佳机会获得最佳心血管健康和生存。在这篇综述中,讨论了 CKD 中 CVD 发生的病理生理学和预防的重要性。

相似文献

1
Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.降低慢性肾脏病儿童心血管疾病负担:预防与损伤控制。
Pediatr Nephrol. 2021 Aug;36(8):2537-2544. doi: 10.1007/s00467-021-05102-y. Epub 2021 Jun 18.
2
Evolution of Cardiovascular Disease During the Transition to End-Stage Renal Disease.向终末期肾病转变过程中心血管疾病的演变
Semin Nephrol. 2017 Mar;37(2):120-131. doi: 10.1016/j.semnephrol.2016.12.002.
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Cardiovascular risk factors in children on dialysis: an update.儿童透析患者的心血管危险因素:最新研究进展。
Pediatr Nephrol. 2020 Jan;35(1):41-57. doi: 10.1007/s00467-018-4125-x. Epub 2018 Oct 31.
5
Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.透析前慢性肾脏病中心血管疾病的临床流行病学
Semin Dial. 2003 Mar-Apr;16(2):101-5. doi: 10.1046/j.1525-139x.2003.16025.x.
6
Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease.巨细胞病毒血清阳性与非透析依赖性慢性肾脏病患者的心血管疾病独立相关。
QJM. 2020 Apr 1;113(4):253-257. doi: 10.1093/qjmed/hcz258.
7
Cardiovascular disease and its relationship with chronic kidney disease.心血管疾病及其与慢性肾脏病的关系。
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2918-26.
8
Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu.亚临床甲状腺功能减退症、肾脏和心脏从正常到尿毒症环境。
Metab Syndr Relat Disord. 2023 Oct;21(8):415-425. doi: 10.1089/met.2023.0057. Epub 2023 Jul 11.
9
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.慢性肾脏病的心血管并发症:来自欧洲肾脏病协会的欧洲肾脏和心血管医学工作组的综述。
Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083.
10
The role of exercise training on cardiovascular risk factors and heart disease in patients with chronic kidney disease G3-G5 and G5D: a Clinical Consensus Statement of the European Association of Preventive Cardiology of the ESC and the European Association of Rehabilitation in Chronic Kidney Disease.运动训练对慢性肾脏病 3-5 期和 5D 期患者心血管风险因素和心脏病的作用:ESC 欧洲预防心脏病学协会和慢性肾脏病康复欧洲协会的临床共识声明。
Eur J Prev Cardiol. 2024 Sep 6;31(12):1493-1515. doi: 10.1093/eurjpc/zwae130.

引用本文的文献

1
Long-term kidney complications in childhood leukemia survivors: a study from the Childhood and Adolescent Leukemia (LEA) project.儿童白血病幸存者的长期肾脏并发症:来自儿童和青少年白血病(LEA)项目的一项研究。
Haematologica. 2025 Sep 1;110(9):1987-1997. doi: 10.3324/haematol.2024.286940. Epub 2025 Apr 3.
2
Identifying children who develop severe chronic kidney disease using primary care records.利用初级保健记录识别患有严重慢性肾病的儿童。
PLoS One. 2025 Feb 10;20(2):e0314084. doi: 10.1371/journal.pone.0314084. eCollection 2025.
3
Assessment of obesity in pediatric kidney transplant recipients: an ongoing challenge.

本文引用的文献

1
Naturally Occurring Stable Calcium Isotope Ratios in Body Compartments Provide a Novel Biomarker of Bone Mineral Balance in Children and Young Adults.天然稳定的钙同位素比值在身体各部位提供了一种新的儿童和青年成骨矿物质平衡生物标志物。
J Bone Miner Res. 2021 Jan;36(1):133-142. doi: 10.1002/jbmr.4158. Epub 2020 Sep 11.
2
Targeting optimal PD management in children: what have we learned from the IPPN registry?目标是为儿童提供最佳 PD 管理:我们从 IPPN 注册处学到了什么?
Pediatr Nephrol. 2021 May;36(5):1053-1063. doi: 10.1007/s00467-020-04598-0. Epub 2020 May 27.
3
Effects of Hemodiafiltration versus Conventional Hemodialysis in Children with ESKD: The HDF, Heart and Height Study.
评估小儿肾移植受者的肥胖情况:一项持续存在的挑战。
Pediatr Nephrol. 2025 Jul;40(7):2113-2116. doi: 10.1007/s00467-025-06706-4. Epub 2025 Feb 6.
4
DOMINÓ Registry: study protocol on mineral and bone disease (DOença MINeral e Óssea) of chronic kidney disease in pediatrics in Brazil.多米诺注册研究:巴西儿童慢性肾脏病矿物质和骨疾病(DOença MINeral e Óssea)的研究方案
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240054. doi: 10.1590/2175-8239-JBN-2024-0054en.
5
Teenagers and young adults with a past of allogenic hematopoietic stem cell transplantation are at significant risk of chronic kidney disease.接受过异基因造血干细胞移植的青少年和年轻人有发生慢性肾脏病的重大风险。
Pediatr Nephrol. 2022 Jun;37(6):1365-1375. doi: 10.1007/s00467-021-05319-x. Epub 2021 Nov 4.
血液透析滤过与常规血液透析对儿童终末期肾病的影响:HDF、心脏和身高研究。
J Am Soc Nephrol. 2019 Apr;30(4):678-691. doi: 10.1681/ASN.2018100990. Epub 2019 Mar 7.
4
Chronic dialysis in children and adolescents: challenges and outcomes.儿童和青少年的慢性透析:挑战与结果
Lancet Child Adolesc Health. 2017 Sep;1(1):68-77. doi: 10.1016/S2352-4642(17)30018-4. Epub 2017 Jul 20.
5
Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.血液透析滤过与传统血液透析对儿童生长及心血管结局的影响——血液透析滤过、心脏与身高(3H)研究
BMC Nephrol. 2018 Aug 10;19(1):199. doi: 10.1186/s12882-018-0998-y.
6
Attitudes of nephrologists towards intensified hemodialysis
.肾病学家对强化血液透析的态度
Clin Nephrol. 2018 Oct;90(4):255-261. doi: 10.5414/CN109350.
7
The interplay between bone and vessels in pediatric CKD: lessons from a single-center study.儿科慢性肾脏病中骨骼与血管的相互作用:单中心研究的启示。
Pediatr Nephrol. 2018 Sep;33(9):1565-1575. doi: 10.1007/s00467-018-3978-3. Epub 2018 Jun 5.
8
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.慢性肾脏病-矿物质和骨异常的诊断、评估、预防和治疗:肾脏病改善全球结局组织 2017 年临床实践指南更新概要。
Ann Intern Med. 2018 Mar 20;168(6):422-430. doi: 10.7326/M17-2640. Epub 2018 Feb 20.
9
Barriers for implementation of intensified hemodialysis: survey results from the International Pediatric Dialysis Network.强化血液透析实施的障碍:来自国际儿科透析网络的调查结果。
Pediatr Nephrol. 2018 Apr;33(4):705-712. doi: 10.1007/s00467-017-3831-0. Epub 2017 Nov 4.
10
Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.儿科慢性肾脏病中心血管疾病的病理生理学和治疗。
Pediatr Nephrol. 2019 Jan;34(1):1-10. doi: 10.1007/s00467-017-3798-x. Epub 2017 Sep 22.